It’s no easy task to utilize AI/ML and mechanistic modeling to discover and develop novel small molecules. Many companies, from biotech start-ups to large pharma, are farming out this aspect of the early drug discovery process—and for good reason. Developing and validating your own internal AI functionalities requires capital and personnel, and it often makes sense to turn to the experts.
At Simulations Plus, we bring together AI-driven design, predictive modeling, and mechanistic simulation in a unified, scientifically grounded approach to discovery. Our team of computational chemists, modelers, and drug development experts works alongside you to transform complexity into clear direction.